Isolated Myoglobinuria with Normal Renal Function
The most likely cause is an underlying metabolic myopathy, specifically a disorder of muscle energy metabolism affecting either glycogen breakdown (glycolytic defects) or fatty acid oxidation, with carnitine palmitoyltransferase (CPT) deficiency and myophosphorylase deficiency being the most common culprits 1.
Clinical Reasoning
The presentation of myoglobinuria with completely normal CBC, BUN/creatinine, and liver function tests is highly characteristic of a metabolic muscle disorder rather than acute rhabdomyolysis with systemic complications. The trace ketones suggest a metabolic stress state, while the 1+ proteinuria represents the myoglobin itself being filtered through the kidneys.
Key Diagnostic Considerations
The normal renal function (BUN/Cr) is crucial here—it indicates either:
- Early presentation before kidney injury develops
- Sufficient hydration/urine output preventing tubular obstruction
- Most importantly: A chronic, recurrent metabolic myopathy rather than massive acute rhabdomyolysis
Most Common Metabolic Causes
Based on systematic biochemical evaluation of idiopathic myoglobinuria 1:
Primary metabolic defects identified (in order of frequency):
- Carnitine palmitoyltransferase (CPT) deficiency (47% of cases with identified enzymopathy)
- Myophosphorylase deficiency (28% of cases)
- Phosphorylase kinase deficiency (11% of cases)
- Myoadenylate deaminase (MAD) deficiency (8% of cases)
- Phosphoglycerate kinase (PGK) deficiency (rare) 2
CPT Deficiency Pattern
CPT deficiency typically presents with 3:
- Recurrent myoglobinuria triggered by prolonged exercise after fasting
- Symptoms during high-fat diet consumption
- Cold weather exposure as trigger
- Muscle cramps, weakness, and malaise
- Delayed ketone production during fasting
- Exercise is the main precipitating factor 1
Glycolytic Defect Pattern
Myophosphorylase and other glycolytic enzyme deficiencies present with 4, 1:
- Exercise-induced myoglobinuria (typically shorter, more intense exercise)
- Forearm ischemic exercise test showing no rise in venous lactate
- "Second wind" phenomenon (absent in glycolytic defects)
Diagnostic Algorithm
Immediate steps to determine etiology:
Detailed trigger history:
- Fasting + prolonged exercise → suspect CPT deficiency
- Brief intense exercise → suspect glycolytic defect
- No clear trigger → consider mitochondrial disorder
Forearm ischemic exercise test (if safe to perform):
- No lactate rise = glycolytic defect
- Normal lactate rise = fatty acid oxidation defect or mitochondrial disorder
Muscle biopsy (performed well after episode) 4:
- Biochemical enzyme analysis for 8 key enzymes
- Lipid droplet accumulation suggests CPT deficiency
- Glycogen content assessment
Molecular genetic testing (increasingly first-line) 4:
- Most definitive diagnostic approach
- Identifies specific genetic mutations
Critical Pitfalls to Avoid
Do not assume normal renal function means no risk: Myoglobin can cause acute kidney injury even with initially normal creatinine 5. The patient needs aggressive hydration and monitoring.
Timing matters: Plasma myoglobin peaks earlier than CPK and may be more sensitive for predicting acute kidney injury risk 5. CPK levels >75,000 IU/L carry >80% risk of acute kidney injury 5.
Not all myoglobinuria shows positive urine dipstick: While myoglobin reacts positively for blood on dipstick, negative to trace blood results had myoglobin ≥1000 μg/L in only 0.4% of cases 6. However, 3+ blood without hematuria had myoglobin ≥1000 μg/L in 31.9% of cases 6.
Immediate Management Priorities
Even with normal renal function currently:
- Aggressive IV fluid resuscitation to maintain urine output >200-300 mL/hour
- Serial creatinine monitoring (can remain normal initially then deteriorate) 7
- Avoid repeat muscle injury until diagnosis established
- Dietary modification if CPT deficiency suspected (avoid fasting, consider carbohydrate loading)
About half of idiopathic myoglobinuria cases will have identifiable metabolic enzymopathies on systematic evaluation 1. The remainder may have defects in pathways not routinely studied (such as beta-oxidation defects) or genetic sarcolemmal defects.